Allurion ® Technologies , a Leading Company Pioneering the Development of Innovative, Scalable and Reliable Weight Loss Experiences, Announced a Major Breakthrough which enhances weight loss program Allurion TM with the launch of its new digital offering health including smart watch Allurion TM health Tracker, the scale connected Allurion ® connected Scale, mobile app Allurion ® and the dashboard Allurion TMClinic Dashboard, the first of a series of new services component following virtual care Allurion TM Virtual Care.
The Allurion connected scale and Health Tracker smartwatch measure all aspects of body condition including weight, body fat, muscle mass, as well as activity data like number of steps, l ‘physical exercise and sleep. These measurements are automatically synchronized with the Allurion mobile app, which organizes and analyzes the data, provides real-time information to the user, and allows it to be shared with the provider and the healthcare team.
The Allurion Clinic Dashboard helps providers understand aggregated patient outcomes and gives them access to real-time information to enable them to personalize care, which ultimately leads to improved outcomes. A true turnkey solution, the Allurion Clinic Dashboard allows providers to track a variety of clinical indicators such as weight loss and patient persistence over time, and compare their performance with others. clinical data around the world.
During 2021, additional features will complement the Allurion Virtual Care suite. They will simplify the monitoring, communication and delivery of care by providers through various instruments such as telemedicine and AI-based weight loss counseling. This suite of instruments, available to all providers who offer the Allurion program, provides ongoing, seamless support and dramatically improves patient satisfaction.
“The Allurion Virtual Care Suite is designed to work in conjunction with the Elipse ® Gastric Balloon and our nutritional and behavioral change program. It enables users to achieve life-changing results and our providers with real-time data and information, says Dr Shantanu Gaur, Co-Founder and CEO of Allurion. Our digital healthcare offering creates an ecosystem for users and our providers that will not only improve short-term outcomes, but also facilitate lifelong weight management. ”
As further proof of its commitment to user satisfaction and the achievement of optimal results, the Company is also announcing today the introduction of the Allurion Assurance Plus warranty program. Patients worldwide using Allurion will now automatically be enrolled in the new Allurion warranty program free of charge. The Allurion Assurance Plus program provides patients with peace of mind by providing that any rare and eligible Elipse ® balloon event will be covered by direct financial assistance.
“Allurion is committed to providing patients with the best patient experience the industry can offer, and their safety is our top priority,” said Dr. Ram Chuttani, MD, Chief Medical Officer of Allurion. We are very pleased to launch the Allurion Assurance Plus guarantee program to provide our patients with increased comfort and confidence throughout their weight loss program. ”
About Allurion Technologies
Allurion Technologies ‘s mission is to help people lead healthy lives by providing innovative, scalable and reliable weight loss experiences. The Company’s flagship product, Allurion Program is a comprehensive weight loss program including Elipse Balloon, the world’s first and only gastric balloon that is swallowable and avoids any invasive procedure, the Allurion Honeymoon from Hunger nutritional and behavior change program, and the Allurion Virtual Care suite including the Allurion connected scale, the Allurion Health Tracker smartwatch, the Allurion mobile app, the Allurion Clinic Dashboard and the Allurion Insights portal. For more information on Allurion, visit the website www.allurion.com. Allurion and Elipse are registered trademarks of Allurion Technologies, Inc. in the United States and worldwide.
The text of the press release resulting from a translation should in no way be considered official. The only authentic version of the press release is that of the press release in its original language. The translation will always have to be compared to the source text, which will set a precedent.
